Advancing BTK Inhibition: Non‑Covalent Bruton Tyrosine Kinase Inhibitors and Their Emerging Role in Canadian Practice. (2025). Actualité hématologique Au Canada, 4(s04), 2–15. https://doi.org/10.58931/cht.2025.4s0469